Langman CB, Greenbaum LA, Sarwal M, Grimm P, Niaudet P, Deschenes G, Cornelissen E, Morin D, Cochat P, Matossian D, Gaillard S, Bagger MJ, Rioux P (2012) A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safety
(PubMed) Handelman GJ, Machlin LJ, Fitch K, Weiter JJ, Dratz EA
BPC-157 is a synthetic peptide studied in laboratory and peptide research involving cellular signaling pathways and tissue-related research applications
Increase to 34 per week, increase per-dose amount to 75100mcg, or switch to a 0.5mg vial that fits a twice-weekly schedule.
Paciorek, J
- Administration: Subcutaneous injection